Zacks Investment Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $43.4M | Sell |
554,423
-8,842
| -2% | -$713K | 0.31% | 84 |
|
|
2026
Q1 | $48.8M | Buy |
563,265
+1,061
| +0.2% | +$102K | 0.39% | 70 |
|
|
2025
Q4 | $54M | Sell |
562,204
-3,907
| -0.7% | -$380K | 0.42% | 65 |
|
|
2025
Q3 | $53.9M | Buy |
566,111
+1,203
| +0.2% | +$111K | 0.43% | 64 |
|
|
2025
Q2 | $49.2M | Buy |
564,908
+4,508
| +0.8% | +$382K | 0.42% | 69 |
|
|
2025
Q1 | $50.4M | Buy |
560,400
+24,953
| +5% | +$2.23M | 0.47% | 61 |
|
|
2024
Q4 | $42.8M | Sell |
535,447
-81,543
| -13% | -$7.06M | 0.4% | 70 |
|
|
2024
Q3 | $55.5M | Buy |
616,990
+59,821
| +11% | +$5.03M | 0.48% | 60 |
|
|
2024
Q2 | $43.9M | Buy |
557,169
+14,500
| +3% | +$1.19M | 0.49% | 53 |
|
|
2024
Q1 | $47.3M | Buy |
542,669
+21,567
| +4% | +$1.84M | 0.5% | 60 |
|
|
2023
Q4 | $42.9M | Sell |
521,102
-39,974
| -7% | -$3.05M | 0.53% | 57 |
|
|
2023
Q3 | $44M | Sell |
561,076
-3,573
| -0.6% | -$299K | 0.57% | 50 |
|
|
2023
Q2 | $49.7M | Buy |
564,649
+2,738
| +0.5% | +$236K | 0.62% | 46 |
|
|
2023
Q1 | $45.3M | Buy |
561,911
+35,645
| +7% | +$2.91M | 0.61% | 50 |
|
|
2022
Q4 | $40.9M | Sell |
526,266
-2,298
| -0.4% | -$186K | 0.57% | 50 |
|
|
2022
Q3 | $42.7M | Buy |
528,564
+14,394
| +3% | +$1.29M | 0.68% | 43 |
|
|
2022
Q2 | $46.1M | Buy |
514,170
+28,117
| +6% | +$2.85M | 0.7% | 45 |
|
|
2022
Q1 | $53.9M | Buy |
486,053
+34,795
| +8% | +$3.68M | 0.75% | 40 |
|
|
2021
Q4 | $46.7M | Buy |
451,258
+1,801
| +0.4% | +$209K | 0.66% | 48 |
|
|
2021
Q3 | $56.3M | Buy |
449,457
+8,456
| +2% | +$1.09M | 0.89% | 36 |
|
|
2021
Q2 | $54.7M | Buy |
441,001
+4,366
| +1% | +$548K | 0.89% | 36 |
|
|
2021
Q1 | $51.6M | Sell |
436,635
-29,167
| -6% | -$3.42M | 0.92% | 30 |
|
|
2020
Q4 | $54.6M | Sell |
465,802
-16,903
| -4% | -$1.86M | 1.01% | 26 |
|
|
2020
Q3 | $50.2M | Sell |
482,705
-12,839
| -3% | -$1.29M | 1.02% | 28 |
|
|
2020
Q2 | $45.4M | Buy |
495,544
+3,271
| +0.7% | +$314K | 1% | 30 |
|
|
2020
Q1 | $44.4M | Sell |
492,273
-4,680
| -0.9% | -$498K | 1.09% | 28 |
|
|
2019
Q4 | $56.4M | Buy |
496,953
+5,452
| +1% | +$598K | 1.06% | 30 |
|
|
2019
Q3 | $53.4M | Buy |
491,501
+12,076
| +3% | +$1.26M | 1.07% | 28 |
|
|
2019
Q2 | $46.7M | Buy |
479,425
+6,498
| +1% | +$593K | 0.96% | 34 |
|
|
2019
Q1 | $43.1M | Sell |
472,927
-10,613
| -2% | -$950K | 0.92% | 34 |
|
|
2018
Q4 | $44M | Sell |
483,540
-2,056
| -0.4% | -$192K | 1.06% | 27 |
|
|
2018
Q3 | $47.8M | Sell |
485,596
-1,727
| -0.4% | -$160K | 1% | 26 |
|
|
2018
Q2 | $41.7M | Buy |
+487,323
| New | +$40.7M | 0.91% | 30 |
|
|
2017
Q1 | – | Sell |
-101,509
| Closed | -$7.23M | – | 689 |
|
|
2016
Q4 | $7.23M | Sell |
101,509
-58,346
| -36% | -$4.58M | 0.21% | 106 |
|
|
2016
Q3 | $13.8M | Buy |
159,855
+2,349
| +1% | +$205K | 0.39% | 72 |
|
|
2016
Q2 | $13.7M | Sell |
157,506
-535
| -0.3% | -$43.3K | 0.42% | 72 |
|
|
2016
Q1 | $11.9M | Buy |
158,041
+52,358
| +50% | +$3.94M | 0.38% | 79 |
|
|
2015
Q4 | $8.13M | Buy |
105,683
+24,600
| +30% | +$1.85M | 0.27% | 107 |
|
|
2015
Q3 | $5.43M | Sell |
81,083
-792
| -1% | -$58.3K | 0.19% | 128 |
|
|
2015
Q2 | $6.07M | Buy |
81,875
+29,787
| +57% | +$2.28M | 0.19% | 124 |
|
|
2015
Q1 | $4.06M | Buy |
+52,088
| New | +$3.95M | 0.13% | 149 |
|
|
2014
Q3 | – | Sell |
-275,541
| Closed | -$17.6M | – | 714 |
|
|
2014
Q2 | $17.6M | Sell |
275,541
-133,158
| -33% | -$8.09M | 0.62% | 46 |
|
|
2014
Q1 | $25.2M | Buy |
408,699
+19,043
| +5% | +$1.11M | 0.93% | 24 |
|
|
2013
Q4 | $22.4M | Buy |
389,656
+165,658
| +74% | +$9.39M | 0.88% | 24 |
|
|
2013
Q3 | $11.9M | Sell |
223,998
-8,301
| -4% | -$447K | 0.52% | 71 |
|
|
2013
Q2 | $12M | Buy |
+232,299
| New | +$11.5M | 0.55% | 60 |
|
Other funds holding MDT
Zacks Investment Management's MDT Position: Q2 2026 in Review
Zacks Investment Management reduced its Medtronic (MDT) stake by 1.6% in Q2 2026, selling an estimated $713K and leaving 554,423 shares worth $43.4M. The position accounts for 0.31% of the portfolio, ranked #84.
Zacks Investment Management first reported a position in MDT in Q2 2013 and has held it in 46 quarters since. The position peaked at $56.4M in Q4 2019. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Zacks Investment Management held 554,423 shares of Medtronic worth $43.4M as of Q2 2026.
- Zacks Investment Management sold 8,842 Medtronic shares in Q2 2026, an estimated $713K.
- Medtronic made up 0.31% of Zacks Investment Management's portfolio in Q2 2026, its #84 holding.
- Zacks Investment Management first reported a position in Medtronic in Q2 2013 and has held it in 46 quarters since.
- Zacks Investment Management's Medtronic position peaked at $56.4M in Q4 2019.
- 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Zacks Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.